The California Department of Motor Vehicles (DMV) has suspended General Motors' Cruise autonomous vehicle deployment and driverless testing permits. This decision comes after the regulator found that General Motors (GM) had misrepresented information about the safety of the autonomous technology.
The DMV stated that Cruise's autonomous vehicles posed an unreasonable risk to public safety and are considered unsafe for operation by the public, according to Reuters.
Major Setback to GM's Self-Driving Technology Unit
The New York Post noted that suspending Cruise's permits significantly setback GM's self-driving technology unit and the emerging autonomous vehicle (AV) industry. This action was prompted by a series of accidents involving Cruise vehicles, leading to concerns about the safety of their technology.
However, this suspension does not affect the company's permit for testing with a safety driver, allowing them to continue evaluating their AVs under controlled conditions.
GM has previously emphasized that Cruise represents a massive growth opportunity. GM CEO Mary Barra has forecasted that Cruise could generate $50 billion in annual revenue by 2030.
Despite the recent setback, GM remains committed to this ambitious target. However, the automaker reported a significant loss of $723 million on Cruise during the third quarter, highlighting the financial strain caused by the suspension and related challenges.
The Autonomous Vehicle Industry Faces Regulatory Scrutiny
The California DMV's decision to suspend GM's Cruise permits reflects the growing public and regulatory scrutiny surrounding autonomous vehicles. U.S. auto safety regulators recently investigated whether Cruise is taking sufficient precautions to safeguard pedestrians with its autonomous robotaxis.
Concerning incidents involving Cruise vehicles led to a request from the regulator for half of the robotaxis to be taken off the roads earlier this year.
The regulator's investigation stems from multiple incidents involving Cruise vehicles operating in San Francisco. In August, a Cruise robotaxi collided with an emergency vehicle, raising questions about the safety of autonomous vehicles.
Additionally, the DMV reviewed a recent incident in which a Cruise AV struck a pedestrian. Cruise stated that a hit-and-run driver had initially hit the pedestrian before being propelled into the AV's path.
Safety Records of Autonomous Vehicles
GM CEO Mary Barra has defended the safety of Cruise's robotaxis, claiming that they have better safety records than human drivers. However, the recent incidents have cast doubt on these assertions. The National Highway Traffic Safety Administration (NHTSA) has received reports of incidents involving Cruise vehicles causing injuries to pedestrians, raising concerns about the safety precautions taken by the company.
"When the AV tried to pull over, it continued before coming to a final stop, pulling the pedestrian forward," the company said.
"Our teams are currently doing an analysis to identify potential enhancements to the AV's response to this kind of extremely rare event," it added.
Photo: Get Cruise Media Resources


Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 



